Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial

被引：17
作者：
Bloch, Orin [1 ]
Parsa, Andrew T. [1 ]
机构：
[1] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷 / 05期
关键词：
WHOLE-BRAIN RADIOTHERAPY; RESECTION; SURVIVAL; EXTENT; BEVACIZUMAB; METASTASES; THERAPY;
D O I：
10.1093/neuonc/nou054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 15 条
[1]   Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article [J].
Bloch, Orin ;
Han, Seunggu J. ;
Cha, Soonmee ;
Sun, Matthew Z. ;
Aghi, Manish K. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Parsa, Andrew T. .
JOURNAL OF NEUROSURGERY, 2012, 117 (06) :1032-1038
[2]  
Chamberlain C, 2011, NEURO-ONCOLOGY, V13, P132
[3]   Should Erlotinib Be Coadministered With Whole-Brain Radiotherapy in Patients With Brain Metastases and Non-Small-Cell Lung Cancer? [J].
Chamberlain, Marc C. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) :3164-3165
[4]   Does Quality of Life Supplant Survival in Patients With Brain Metastasis? [J].
Chamberlain, Marc C. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) :2635-2635
[5]   Are Prognostic Factors for Leptomeningeal Metastases Defined Sufficiently to Permit Tailored Treatment? [J].
Chamberlain, Marc C. ;
Goulart, Bernardo H. L. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) :E66-E67
[6]   Does RTOG 9802 Change Practice With Respect to Newly Diagnosed Low-Grade Glioma? [J].
Chamberlain, Marc C. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :652-653
[7]   Is Graded Prognostic Assessment an Improvement Compared With Radiation Therapy Oncology Group's Recursive Partitioning Analysis Classification for Brain Metastases? [J].
Chamberlain, Marc C. ;
Silbergeld, Daniel L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) :3315-3316
[8]   Is There a Role for Whole Brain Radiotherapy in the Treatment of Leptomeningeal Metastases? [J].
Chamberlain, Marc C. ;
Eaton, Keith .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) :1204-1204
[9]   Surgery, a prognostic marker for progression-free survival? [J].
Chamberlain, Marc C. ;
Silbergeld, Daniel L. .
NEURO-ONCOLOGY, 2012, 14 (04) :390-391
[10]   Treatment of Glioblastoma with Bevacizumab Has a New Standard Therapy been Defined? [J].
Chamberlain, Marc C. .
CNS DRUGS, 2011, 25 (10) :815-818
12